gilead sciences inc (GILD:NASDAQ GS)
Kevin B. Young CBE
Senior Advisor, Gilead Sciences Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2013
Mr. Kevin B. Young, CBE has been Senior Advisor of Gilead Sciences Inc. since February 4, 2014. Mr. Young served as an Executive Vice President of Commercial Operations at Gilead Sciences Inc. from September 14, 2004 to February 4, 2014. He is a Executive Vice President of Commercial Operations at Gilead Palo Alto, Inc. He served as Head of the U.S. Inflammation Business Unit and led the re-launch of Enbrel following the acquisition of Immunex. Mr. Young has an Undergraduate ...
333 Lakeside DrivePhone: 650-574-3000
Foster City, California 94404
Board Members Memberships*There is no Board Members Memberships data available.
University of Michigan
Liverpool John Moores University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Olivier Brandicourt||Chief Executive Officer and Director|
|--||Compensation as of Fiscal Year 2014.|